Soligenix
SNGX
#10565
Rank
NZ$11.68 M
Marketcap
NZ$0.79
Share price
7.17%
Change (1 day)
-74.55%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -NZ$21.42 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$16.11 Million a decrease over its 2023 earnings that were of -NZ$13.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$21.42 Million32.93%
2024 -NZ$16.11 Million22.96%
2023 -NZ$13.11 Million-45.74%
2022 -NZ$24.15 Million11.88%
2021 -NZ$21.58 Million-32.37%
2020 -NZ$31.91 Million83.18%
2019 -NZ$17.42 Million11.57%
2018 -NZ$15.62 Million19.29%
2017 -NZ$13.09 Million33%
2016 -NZ$9.84 Million-19.7%
2015 -NZ$12.26 Million5.16%
2014 -NZ$11.66 Million
2010 -NZ$13.16 Million26.12%
2009 -NZ$10.43 Million75.1%
2008 -NZ$5.96 Million-45.38%
2007 -NZ$10.91 Million-22.84%
2006 -NZ$14.13 Million66.15%
2005 -NZ$8.51 Million-16.65%
2004 -NZ$10.21 Million13.28%
2003 -NZ$9.01 Million-11.88%
2002 -NZ$10.23 Million-59.44%
2001 -NZ$25.21 Million378.18%
2000 -NZ$5.28 Million-38.53%
1999 -NZ$8.58 Million-18.43%
1998 -NZ$10.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.76 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.25 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.19 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$31.29 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$71.97 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.91 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$4.75 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA